SCHEMBL8939792

SCHEMBL8939792

CCCCOc1ccc[c]c1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 1/20 0.46
HRH1 P35367 5/20 0.43
TSHR P16473 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
DRD2 P14416 3/20 0.41
DRD1 P21728 3/20 0.41
DRD3 P35462 2/20 0.41
LMNA P02545 1/20 0.41
DRD4 P21917 2/20 0.40
DRD5 P21918 2/20 0.40
LTA4H P09960 2/20 0.40
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8939785 0.86 HTR1A (0.42) HRH1TSHRL3MBTL1DRD2DRD1
SCHEMBL27660943 0.82 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19L3MBTL1CYP3A4
SCHEMBL8939743 0.81 MAPT (0.49) L3MBTL1DRD2LTA4HSMN1; SMN2
SCHEMBL8859963 0.79 LTA4H (0.44) CYP2C19TP53LTA4HHPGD
SCHEMBL8939734 0.76 HPGD (0.41) CYP1A2TSHRL3MBTL1CYP3A4LMNA
SCHEMBL5146718 0.76 HRH1 (0.71) CYP1A2CYP2C9HRH1TSHRL3MBTL1
SCHEMBL8939699 0.75 ADRA1D (0.39) TSHRLMNA
SCHEMBL16961397 0.74 MCHR1 (0.38) CYP1A2CYP2C9CYP2C19L3MBTL1TP53
SCHEMBL677482 0.74 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19L3MBTL1CYP3A4
SCHEMBL10841925 0.74 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516797-A SUPPRESSING GRAFT REJECTION VERTEX PHARMACEUTICALS, INCORPORATED (US) 1996-05-14 US disclosed
US-5330993-A Immunosuppressive compounds VERTEX PHARMACEUTICALS, INC. (US) 1994-07-19 US disclosed